Flexible long-chain substituted quinoxalines as G-quadruplex binders exert antitumor effects via cGAS-STING immunomodulatory pathway
- PMID: 40730306
- DOI: 10.1016/j.ijbiomac.2025.146352
Flexible long-chain substituted quinoxalines as G-quadruplex binders exert antitumor effects via cGAS-STING immunomodulatory pathway
Abstract
cGAS-STING signaling is a critical mechanism responsible for detecting cytosolic DNA, among a variety of pathways activating innate immunity, making it as an important target for cancer immunotherapy. G-quadruplexes (G4s) frequently forming in telomeres and promoters are able to regulate biological processes. Many compounds targeting G4s are reported with the capability of triggering DNA damage, while leakage of damaged DNA to cytoplasm can be the signal to stimulate innate immunity. Nevertheless, whether small molecule G4 ligands can activate cGAS-STING pathway is seldomly discussed. In this study, we designed and synthesized three compounds by decorating our previously reported quinoxaline scaffold with various flexible long side chains. Among them, QL-3 was identified as the most promising ligand with binding and stabilizing properties to G4s in vitro. Moreover, QL-3 triggered DNA damage in 4 T1 cells, resulting in the activation of cGAS-STING-TBK1-IRF3 pathway and the subsequent ICD. Finally, QL-3 was proved to be a potent anticancer reagent in BALB/c mice implanted with 4 T1 cells, with the immunomodulatory effects on T cells and cytokines displayed. In summary, this study offered a new strategy for developing G4 ligands for tumor immunotherapy, especially through cGAS-STING pathway.
Keywords: G-quadruplex; Quinoxaline; cGAS-STING.
Copyright © 2025 Elsevier B.V. All rights reserved.
Conflict of interest statement
Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Similar articles
-
Prescription of Controlled Substances: Benefits and Risks.2025 Jul 6. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. 2025 Jul 6. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan–. PMID: 30726003 Free Books & Documents.
-
DNMT inhibition epigenetically restores the cGAS-STING pathway and activates RIG-I/MDA5-MAVS to enhance antitumor immunity.Acta Pharmacol Sin. 2025 Aug 19. doi: 10.1038/s41401-025-01639-y. Online ahead of print. Acta Pharmacol Sin. 2025. PMID: 40830678
-
Classifying cGAS-STING Activity Links Chromosomal Instability with Immunotherapy Response in Metastatic Bladder Cancer.Cancer Res Commun. 2022 Aug 4;2(8):762-771. doi: 10.1158/2767-9764.CRC-22-0047. eCollection 2022 Aug. Cancer Res Commun. 2022. PMID: 36923311 Free PMC article.
-
Management of urinary stones by experts in stone disease (ESD 2025).Arch Ital Urol Androl. 2025 Jun 30;97(2):14085. doi: 10.4081/aiua.2025.14085. Epub 2025 Jun 30. Arch Ital Urol Androl. 2025. PMID: 40583613 Review.
-
The cGAS-STING pathway in cancer immunity: dual roles, therapeutic strategies, and clinical challenges.Essays Biochem. 2025 Mar 7;69(2):EBC20253006. doi: 10.1042/EBC20253006. Essays Biochem. 2025. PMID: 40052963 Free PMC article. Review.
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous